Characterization of systemic and mucosal humoral immune responses to an adjuvanted intranasal SARS-CoV-2 protein subunit vaccine candidate in mice

From National Research Council Canada

  1. (PDF, 1.9 MiB)
DOIResolve DOI:
AuthorSearch for: ; Search for: ; Search for: 1; Search for: 1; Search for: 1ORCID identifier:; Search for: 1; Search for: ORCID identifier:
Name affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FunderSearch for: Canadian Institutes of Health Research; Search for: NRC’s Pandemic Response Challenge Program
FormatText, Article
SubjectCOVID-19; SARS-CoV-2; subunit vaccine; spike; receptor binding domain; mucosal immunity; AMVAD; intranasal vaccine
Publication date
Peer reviewedYes
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierda4532b6-c265-4e93-b7fc-2783fca26722
Record created2023-08-02
Record modified2023-08-02
Date modified: